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There is substantial evidence that oxidative stress causes negative outcomes in many cell and 
tissue types. This is especially true of skeletal muscle, as it is continually subjected to various 
sources of reactive oxygen species (ROS). Oxidative stress in muscle has been linked to several 
disease states as well as to the normal aging process. Oxidative stress has also been associated 
with increased apoptotic signalling. Furthermore, elevated apoptosis is consistently observed in 
aged skeletal muscle and is thought to be one of the mechanisms of age-related muscle atrophy. 
Due to its post-mitotic nature, skeletal muscle may be more susceptible to the harmful effects of 
oxidative stress in light of its limited regenerative capacity. As a protective measure, a 
sophisticated antioxidant system exists in muscle consisting of both enzymatic (superoxide 
dismutases (SOD’s), catalase, glutathione peroxidase) and non-enzymatic elements (glutathione: 
GSH). GSH is a ubiquitously expressed tripeptide essential to maintenance of the redox status of 
the cell. Its role in skeletal muscle apoptosis, especially in different muscle types, is currently 
unclear. To elucidate the potential role of GSH in skeletal muscle apoptosis and oxidative stress, 
L-buthionine-[S,R]-sulfoximine (BSO) was used to deplete GSH in young (34.85 ± 0.68 wks) 
and old (69.11 ± 3.61 wks) male Sprague-Dawley rats. Thiol levels (GSH, GSSG), ROS 
production, 4-hydroxy-2-nonenal (4HNE) levels, DNA fragmentation and apoptosis-related 
protein expression were examined in soleus (SOL) and white gastrocnemius (WG) muscle. BSO 
led to significant GSH depletion (89% in SOL, 96% in WG) compared to age-matched controls. 
Catalase upregulation, in the absence of change in SOD levels, was evident as a result of BSO 
treatment and advancing age in both muscle tissues. BSO treatment also resulted in increased 
DNA fragmentation in WG and SOL, with elevated ROS production in SOL only; both of these 
effects were independent of age. Advancing age resulted in elevated caspase activity and Hsp70 
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protein content, with a concomitant decrease in anti-apoptotic ARC in SOL but not WG. 
Additionally, ROS production, 4HNE content, DNA fragmentation and ARC levels were all 
significantly elevated in SOL compared to WG. These data indicate that SOL may be subjected 
to a state of elevated cellular stress.  There is also some evidence that GSH depletion increases 
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Apoptosis is a tightly regulated, highly ordered mode of cell death also referred to as 
programmed cell death.1 This process occurs through a series of cellular events that aid in the 
removal of unnecessary or damaged cells from an organism. For example, during 
embryogenesis, apoptosis of skin cells occurs between the digits of the hand which allows for 
the proper formation of the fingers.2 Apoptosis is also implicated in several disease states, such 
as HIV/AIDS where widespread T cell-specific apoptosis occurs,3, 4 cardiovascular diseases 
where apoptosis can be altered in several tissues such as heart, 5, 6 blood vessels7, 8 and skeletal 
muscle,9 and cancer where decreased apoptotic cell death prolongs malignant cell survival. 4, 10, 
11, 12 
The hallmark morphological features of apoptosis include cell shrinkage, chromatin 
condensation, membrane blebbing, and formation of apoptotic bodies.13 Apoptosis is a type of 
cell death that causes little damage to the surrounding cellular environment, unlike what is 
commonly observed when cells die by necrosis.1 Along with organelle swelling, loss of 
membrane integrity and cell lysis, this latter form of cellular demise involves a large 
inflammatory response at the site of injury.14 This leads to further damage or death of 
surrounding cells by initiating an exaggerated immune response, an event not typically 
observed during apoptotic cell death.1 While mention of necrosis is important to the concept of 
cell death, the remainder of this thesis will focus on apoptotic cell death, with particular 





Caspases as the “executioners” of apoptosis 
A defining point of the apoptotic death program is the reliance on a family of specialized 
proteolytic enzymes to bring about cell death. Caspases, or cysteine-aspartate proteases, are 
enzymes that cleave target proteins between cysteine and aspartic acid residues.15 These 
enzymes can be divided into two groups, namely the initiator caspases, with the principal 
members consisting of caspases-8 and -9, whose activation leads to subsequent cleavage and 
activation of effector, or terminal, caspases such as caspases-3, -6, -7.16 Caspases can cleave 
other downstream proteases or can activate effector enzymes that play a role in DNA 
fragmentation (ie. caspase-dependent DNAse).17, 18 Caspase activation is both selective and 
very specific in that only certain signals initiate caspase signalling cascades, and only certain 
caspases will be activated depending on the nature of a particular signal. For example, binding 
of specific death ligands to their extracellular receptors, as seen in the extrinsic apoptotic 
pathway, preferentially activates caspase-8, which then transduces the death signal culminating 
in eventual cell death.19, 20 The death signal is propagated by caspases through their ability to 
cleave other caspase zymogens, or procaspases located downstream in the signalling cascade, 
as seen with caspase-8-mediated caspase-3 cleavage.19, 20 Additionally, certain caspases also 
undergo activation through oligomerization-induced autoproteolysis as observed with caspase-
821, 22 and caspase-2 activation.23 
The extrinsic apoptotic pathway 
There are several pathways through which apoptosis can occur. In the extrinsic pathway 
(Figure 1; left side), specialized cell-surface receptors, or death receptors, are stimulated with 
their specific death ligand, leading to intracellular death signal propagation.24 Common death 
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receptors include Fas or CD95, Tumour Necrosis Factor Receptor 1 (TNFR1), and TNF 
Related Apoptosis-Inducing Ligand (TRAIL) Receptors 1 and 2, with their associated death 
ligands, Fas ligand, TNF-α and TRAIL.24 Upon appropriate ligand binding, death domains 
found on the intracellular portion of the death receptors are activated; these include Fas-
associated death domain (FADD)25, 26 or TNFR-associated death domain (TRADD).27 Death 
domain activation leads to assembly of the death-inducing signalling complex (DISC).28, 29 
One of the components of the DISC is procaspase-8, a zymogen activated by proximity-
induced oligomerization with the death effector domains (DED) belonging to FADD.21, 22  
Upon DISC assembly, the mature, initiator form of caspase-8 is released.21, 30 Caspase-8 
proteolytically cleaves cytosolic procaspase-3 to its active effector, caspase-3.19, 20 This latter 
enzyme is responsible for large-scale cellular proteolysis and DNA fragmentation17, 18 and is 
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BH3 domain (ie. Bid).34 On the other hand, the anti-apoptotic members are part of the Bcl-2 
subfamily and contain at least BH1 and BH2, with some members containing all 4 BH domains 
(ie. Bcl-2, Bcl-xL).34 The distribution of these BH domains is significant when considering the 
ways in which these proteins interact during apoptotic cell death. The BH3 domain is an 
essential component in both the anti-apoptotic and pro-apoptotic dimerizations that occur 
during Bax-Bcl-2 or Bax-Bax interactions, respectively.35  
  In most biological systems, pro-apoptotic Bax and anti-apoptotic Bcl-2 are the primary 
Bcl-2 family members of interest, as their opposing effects on mitochondria are so intimately 
tied to cell survival.35, 36, 37, 38, 39 The balance between these proteins, the Bax:Bcl-2 ratio, is a 
frequently used measure of a cell’s susceptibility to apoptotic cell death40 , given the pivotal 
role of the Bcl-2 family members in regulating cell death.35, 37, 38, 39 In terms of its pro-
apoptotic role, Bax is primarily localized in the cytosol in healthy cells but translocates to the 
mitochondria as a result of an apoptotic stimulus and is inserted into the outer mitochondrial 
membrane. This leads to pore formation, also known as the mitochondrial permeability 
transition,39, 41 subsequent loss of membrane potential and release of mitochondrial apoptosis-
related factors.31, 32, 33 Bcl-2 inhibits mitochondrial pore formation by heterodimerization with 
Bax at the mitochondrial outer membrane, thus preventing or at very least delaying release of 
apoptotic factors.35 
When the apoptotic balance is shifted towards mitochondrial pore formation or 
membrane disruption, pro-apoptotic factors can be released into the cytosol which initiates 
apoptosis through distinct mechanisms. For example, cytochrome c can be released from the 
mitochondria31, 39 and binds with Apoptotic Protease-Activating Factor-1 (Apaf-1), 
procaspase-9 and 2-deoxy-ATP in the cytosol.42, 43 This results in the formation of the 
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apoptosome, and is a necessary component in self-cleavage and activation of procaspase-9.42, 43 
Caspase-9 can then cleave procaspase-3, permitting large-scale proteolysis in the cell.17, 18 In 
addition, pore formation permits release of other apoptogenic proteins, such as Smac, which 
can indirectly activate caspases by inhibiting the action of a set of caspase inhibitors known as 
the Inhibitor of Apoptosis Proteins (IAPs).33  
Lastly, there is evidence that both the intrinsic and extrinsic pathways may converge 
during apoptotic signalling.44 In this sequence of events, activation of the intrinsic apoptotic 
machinery leads to caspase-8-mediated cleavage of the Bcl-2 family member Bid (Figure 1).44 
This pro-apoptotic factor is found in the cytosol and upon truncation by caspase-8, inserts into 
the outer mitochondrial membrane and contributes to pore formation and release of 
apoptogenic factors.37 
Caspase-independent and calcium-mediated apoptosis 
Apoptotic cell death can also be caused by two additional pathways. The first of these is the 
caspase-independent mitochondria-mediated pathway, which involves the release of the pro-
apoptotic proteins Apoptosis-Inducing Factor (AIF)32 and Endonuclease G (Endo G)45) from 
mitochondria. AIF is a flavenoid protein normally located in the mitochondria intermembrane 
space that possesses both electron acceptor/donor characteristics typical of NADH oxidases in 
addition to a death effector role.46 Upon exposure to apoptotic stimuli, AIF is released into the 
cytosol, where it then translocates to the nucleus to cause chromatin condensation and large-
scale DNA fragmentation.32, 47, 48 Endo G is a nuclease located in the mitochondria, where its 
role is to produce RNA primers for DNA polymerase gamma.49 However, apoptotic stimuli can 
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induce EndoG release from the mitochondria and subsequent translocation to the nucleus 
where, similar to AIF, it induces large-scale DNA fragmentation.45  
Another series of events culminating in apoptotic cell death is the calcium-dependent 
calpain-mediated pathway. In this particular case, the calcium-dependent proteases calpains are 
activated by increased intracellular calcium concentrations50, which activate caspase-12 
released from the endoplasmic reticulum, leading to downstream activation of caspase-3.51  
Apoptosis in skeletal muscle 
The apoptotic pathways and molecules reviewed above are biologically conserved and are 
similar in many cellular systems, though the intricacies of the pathways may vary slightly 
depending on the tissue. A special case is skeletal muscle, which possesses some unique 
features with respect to apoptotic signalling and cell death. In most systems, an entire cell is 
typically removed when apoptosis is triggered.4, 10, 52, 53, 54 However, due to the multi-
nucleated nature of skeletal muscle, it can undergo a process known as myonuclear apoptosis, 
whereby only certain individual nuclei and their associated cytoplasmic portions are lost 
(Figure 2).55, 56 This restricted loss is speculated, in the short term, to allow for preservation of 
muscle fiber integrity, resulting in maintenance of overall fiber number. However, this loss of 
nuclei would result in fiber and muscle atrophy through loss of that associated cytoplasmic 
portion, or myonuclear domain, of individual myonuclei.55 Work conducted in rodent models 
of muscle atrophy, including hindlimb unloading57, 58 and spaceflight,59 has demonstrated 
decreased myonuclear number concomitant with a decreased myonuclear domain, events 
which are believed to be a primary cause of muscle fiber atrophy.55, 60 The post-mitotic nature 
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Bax to the mitochondria.65, 66 ARC also interacts with Fas and FADD, impairing death receptor 
activation, DISC assembly and subsequent caspase-8 activation.62, 65  
Lastly, skeletal muscle is made up of several fiber types that vary in their metabolic 
characteristics, contractile properties, morphology, and mitochondrial content.67, 68 For 
example, soleus is composed mainly of type I, or slow-twitch fibers and has a high oxidative 
capacity due to its elevated mitochondrial content. In contrast, extensor digitorum longus 
(EDL) is a glycolytic, fast-twitch muscle composed mainly of type IIB fibers with lower 
mitochondrial content.68, 69 Given the importance of mitochondria in apoptosis, fiber type 
differences or alteration in mitochondrial content may influence apoptotic signalling. 
Therefore, differences in apoptotic signalling and expression may occur across different 
muscle fibers.  
There is evidence of differential apoptotic signalling in fast and slow muscles, which 
adds another level of complexity to understanding the mechanisms of skeletal muscle 
apoptosis. For example, previous work has shown that the expression of ARC is differentially 
expressed in different fibers.70 Recent work in our lab has shown that the expression of 
apoptosis-related proteins, such as AIF, Smac, cytochrome c, Hsp70, ARC and Bcl-2, is 
increased in slow, more oxidative muscle fiber types. In addition to these protein expression 
differences, caspase-3, -8, and -9 activity, as well as basal levels of DNA fragmentation are 
higher in red portions of the gastrocnemius versus white portions of this same muscle 
(McMillan & Quadrilatero, 2010). There is also some evidence of selective apoptosis or 
apoptotic signalling in specific muscles of a particular fiber type in aging.71, 72, 73 For instance, 
Bax and caspase-3 content have been shown to be increased in EDL, but not soleus, with 
advancing age in rats.73 TNF-α signalling is significantly elevated in superficial vastus lateralis 
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(predominantly type II muscle) compared to soleus muscle of old rats.72 Although evidence of 
differential apoptosis or apoptotic signals in particular fiber types exists, further research is 
needed to better define apoptotic signalling in different types of skeletal muscle during aging 
and other disease states. 
Cellular effects of oxidative stress  
Oxidative stress occurs due to an imbalance between cellular oxidants or reactive oxygen 
species (ROS) and antioxidants, favouring higher oxidant concentration or production.74 Some 
common cellular oxidants include hydrogen peroxide (H2O2), superoxide anion (O2·-), 
hydroxyl radical (OH·), and hydroxyl anion (OH-).75 While an increased proportion of oxidants 
can be damaging in the long run, ROS production plays an essential role in cell signal 
transduction and adaptation. For example, the activity of antioxidant enzymes, such as 
MnSOD76, 77 and catalase, 78 is upregulated in response to increased ROS production in skeletal 
muscle. In fact, inhibition of intracellular ROS production prevents activation of the 
MAPK/NF-κB signalling pathway in muscle that is primarily responsible for the above-
mentioned upregulations.79 Furthermore, recent work suggests that expression of peroxisome 
proliferator-activated receptor-γ coactivator-1α (PGC-1α), a powerful inducer of mitochondrial 
biogenesis, is increased 5.6-fold in rodent vastus lateralis muscle due to exhaustive exercise 
and associated ROS production.80  
While ROS mediate positive signalling events, they can also result in more oxidative 
stress. This can result in the oxidation of proteins, lipids, and DNA, and has been linked to the 
development and maintenance of several disease states, such as diabetes,81 cardiovascular 
diseases,82, 83 and Duchenne muscular dystrophy.84, 85 One proposed mechanism for the link 
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between oxidative stress and disease is through modulation of apoptosis. Accumulating 
evidence suggests a role for the mitochondria in mediating oxidative stress by way of electron 
leak from the electron transport chain through incomplete reduction of molecular oxygen.86, 87 
This phenomenon can be induced in vitro in several ways, one of which is through direct 
addition of oxidant substances to cell culture media. A study examining the effects of 
mitochondria-targeted antioxidants used t-butylhydroperoxide, a powerful oxidant, to treat N2A 
cells, resulting in a dose-dependent increase in intracellular ROS production and a concomitant 
decrease in cell viability.88 Inhibition of certain elements of the electron transport chain also 
leads to electron leak and subsequent ROS production. In particular, myxothiazole and 
antimycin A (both mitochondrial complex III inhibitors) result in accumulation of electrons at 
complex III, promoting leak and formation of various ROS, such as H2O2 in heart, kidney, and 
skeletal muscle mitochondria.89  
Two other significant sources of ROS include the xanthine oxidase and the NADPH 
oxidase enzyme systems. Xanthine oxidase (XO) is found in the cytosol of skeletal muscle, 
where it plays a major role in ROS production.83, 90, 91, 92 It produces elevated levels of 
superoxide and hydrogen peroxide, as observed during ischemia-reperfusion injury of 
gastrocnemius muscles in rats.83 Its activity has been shown to increase, along with markers of 
oxidative stress including protein carbonyls and lipid peroxides, in gastrocnemius muscles of 
rats exposed to a contraction-induced claudication exercise protocol.91 On the other hand, 
NADPH oxidase produces superoxide anion that is rapidly dismutated to hydrogen peroxide, 
similar to the reactions mediated by xanthine oxidase. However, its cellular localization differs, 
in that NADPH oxidase is localized at the sarcolemma,93 and in the t-tubules of skeletal 
muscle.94 Skeletal muscle insulin resistance has recently been linked with angiotensin-II-
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mediated ROS signalling involving NADPH oxidase, leading to activation of nuclear factor-
κB.95 There is also evidence that skeletal muscle sarcoplasmic reticulum contains a NADH 
oxidase that produces high levels of superoxide radical.96  
With the abundant sources of oxidative stress outlined above comes the potential for 
damage both to intracellular structures and pro-survival factors. It has been demonstrated that 
apoptosome formation, a necessary step in caspase-9 activation and subsequent cell death, is 
intimately dependent upon ROS generation or leak of oxidants from the mitochondria.97 
Several studies have established a link between increasing levels of oxidative stress and 
subsequent elevations in apoptotic signalling. In particular, in vitro studies using the C2C12 
mouse myoblast cell line have shown dose-dependent increases in DNA fragmentation, 
measured by TUNEL staining, a specific dye that stains for DNA strand breaks, and DNA 
laddering assessed by electrophoresis, upon treatment with hydrogen peroxide.98 Recent 
evidence has shown that anti-apoptotic ARC protein levels are decreased via the ubiquitin-
proteasome pathway in response to apoptotic stimuli such as oxidative stress.99 Loss of 
mitochondrial membrane potential, accompanied by cytochrome c release and downregulation 
of ARC protein levels, have been observed in rat embryonic cardiac cells as a result of 
exposure to H2O2.100 Similar releases of cytochrome c, as well as elevated DNA fragmentation, 
have been observed in murine macrophage cells exposed to increasing concentrations of 4-
hydroxy-2,3-nonenal (4-HNE; an aldehydic by-product of lipid peroxidation).101 
In further support of the link between oxidative stress and apoptosis, recent evidence 
indicates a role for antioxidants in preventing apoptosis in certain cell types and tissues. For 
instance, human satellite cells exposed to H2O2 show elevated TUNEL staining as well as 
increased protein carbonyl content, markers of apoptosis and oxidative stress, respectively.50 
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When these same cells were exposed to Oligopin, a natural antioxidant compound found in 
white pine bark, cell viability increased and all evidence of H2O2-induced apoptotic cell death 
was abolished.50 Oxidative stress caused by inclusion of 4-HNE in growth media of Swiss 3T3 
fibroblasts causes significant, dose-dependent DNA fragmentation and loss of cell viability; the 
antioxidant resveratrol has been shown to protect against these effects.102 Additionally, studies 
employing knockout models of antioxidant enzymes show similar effects attributed to 
oxidative stress-mediated apoptosis. Mice heterozygous for Sod2 (or MnSOD), an important 
mitochondrial ROS scavenger, show increased sensitivity to mitochondrial permeability 
transition formation and subsequent release of cytochrome c upon challenge with calcium or t-
butylhydroperoxide; the former is a commonly used source of ROS for in vitro 
experimentation.103 Lens epithelium cells from Sod2 heterozygotic mice show dramatic 
mitochondrial damage, cytochrome c leak, caspase-3 activation and increased cell death 
compared to wild-type controls.104 Transgenic mice that selectively overexpress human 
catalase, an important endogenous H2O2 detoxifier,  in the mitochondria of skeletal and cardiac 
muscle display decreased H2O2 production from cardiac mitochondria compared to controls.105 
They also display increased lifespan, as well as decreased oxidative DNA damage throughout 
their lives, evidenced by decreased 8-hydroxydeoxyguanosine (8-OHdG) levels.105 Similar 
protective effects of catalase overexpression have been observed in a murine cancer cell line, 
resulting in increased tumour growth.106 There is also evidence for the deleterious effects of 
depletion of endogenous antioxidants, most notably reduced glutathione (GSH); however, this 
will be discussed in detail below. These studies highlight the link between apoptosis and redox 
status and suggest that conditions associated with increased oxidative stress may negatively 
influence apoptotic signalling. 
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Oxidative stress, aging and skeletal muscle apoptosis 
It is proposed that a lifetime of electron flow through the mitochondria leads to cumulative 
damage by way of free radical production, particularly in post-mitotic tissues such as skeletal 
muscle;87 this is known as the free radical or mitochondrial theory of aging. In the last several 
decades, scientists have begun to make a connection between normal aging and oxidative 
stress, especially with regards to skeletal muscle aging.107, 108, 109, 110, 111 For example, aged 
animals display higher basal ROS production than their younger counterparts,107 as well as 
higher protein carbonyl content and reduced expression of sulfhydryl groups in skeletal muscle 
mitochondria.109 ROS have been shown to play an important role in age-associated 
mitochondrial dysfunction.108, 111  
A common condition of aging in skeletal muscle is known as sarcopenia, involving 
significant loss of muscle mass and function, along with decreased basal metabolic rate.112 In 
addition to this gradual loss of function, aging in skeletal muscle is also associated with 
selective loss of type II (fast-twitch) fibers, decreased muscle cross-sectional area, and general 
muscular dysfunction.78 The mechanism of this selective loss of muscle fibers and associated 
muscle atrophy has been suggested to involve both oxidative stress and elevated levels of 
apoptosis.56, 64, 72, 73, 76, 113 For instance, in aged humans displaying a high loss of type II 
muscle fibers, total superoxide dismutase (SOD) activity is significantly decreased, while 
markers of lipid peroxidation are increased.76 In frail elderly humans, mRNA and protein levels 




Animal studies using rodent models have shown comparable changes to humans. 
Specifically, muscles containing a higher proportion of type II fibers (ie. plantaris versus 
soleus) show elevated extrinsic pathway activation and specific fiber loss,64 while older 
animals (24 months old) experience a 50% increase in mono- and oligonucleosomal DNA 
fragmentation compared to adult (6 month old) animals.56 Additionally, caspase-3 is increased 
in aged EDL with no significant changes observed in soleus, providing further support for the 
selective loss of Type II fibers in aging.73 TNF-α signalling is significantly elevated in old 
superficial vastus lateralis (predominantly type II muscle) compared to old soleus muscle.72 
Conversely, there is some evidence for increased apoptosis in type-I dominant soleus muscle of 
old animals, evaluated through increased apoptotic index and smaller cross-sectional area.71 
Furthermore, the more oxidative soleus muscle of rats shows a high basal level of pro-
apoptotic Bax protein expression with a concomitant lower level of anti-apoptotic Bcl-2; the 
reverse trends are seen in the glycolytic, white gastrocnemius muscle, indicating a greater 
potential for apoptotic signalling in the more oxidative muscle type.114 Yet others have shown 
elevated DNA fragmentation in both aged soleus and EDL muscles.73 Taken together, these 
studies support the notion that apoptosis is elevated in skeletal muscle during aging. However, 
this evidence also indicates that the current consensus on selective fiber loss and aging-related 
muscle atrophy requires further clarification. 
Glutathione: an important regulator of cellular redox status 
Antioxidant enzymes and compounds are vital to maintenance of the delicate cellular redox 
balance. While many such compounds can be obtained from foods and supplements 
(exogenous antioxidants), the body has developed several endogenous defences against 
oxidative insult.115, 116, 117 Specifically, the superoxide dismutases (CuZn- and Mn-containing) 
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are cellular enzymes that reduce the highly damaging superoxide anion (O2·-) to hydrogen 
peroxide and molecular oxygen with the help of hydrogen.117 Catalase is another important 
ROS detoxifier that exerts its action downstream of the superoxide dismutases by detoxifying 
H2O2 to water and molecular oxygen.117 Another major intracellular antioxidant is reduced 
glutathione (GSH). It is expressed in all mammalian tissues, with levels varying from 0.2 mM 
to 10 mM depending on tissue type.116 This water-soluble tripeptide is the major intracellular 
thiol composed of glutamate, glycine and cysteine and is synthesized in a two-step process. 
The first, rate-limiting, step consists of formation of the dipeptide γ-glutamylcysteine through 
ligation of L-cysteine and L-glutamate via the action of the enzyme γ-glutamylcysteine 
synthetase (γ-GCS, or Glutamate-L-Cysteine Ligase).118 The second step is catalyzed by GSH 
synthetase, which adds a glycine residue to γ-glutamylcysteine, resulting in the fully functional 
tripeptide.119  
Typically, glutathione is present in its reduced form (GSH) in the cell and may be 
oxidized to glutathione disulfide (GSSG) via detoxification of ROS by the glutathione 
peroxidase (GPx) enzyme system to which it contributes reducing equivalents.120 It is rapidly 
reduced back to GSH by GSSG reductase (GR),121 thus preserving the reducing cellular 
environment. There is a demonstrated relationship between vitamin C, an important water-
soluble exogenous antioxidant, and GSH in their ability to “spare” each other through 
reduction reactions.122 In particular, studies have shown that GSH is essential in maintaining 
the reduced form of vitamin C (ascorbate) in vivo, as depletion of GSH leads to oxidation of 
ascorbate to dehydroascorbate which is degraded and lost.123 Similar mechanisms of mutual 
sparing have also been observed between vitamin E (an exogenous lipid-soluble antioxidant) 
and GSH, whereby each exerts its respective antioxidant activities to protect the other from 
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peroxide modification.124 In addition, GSH can modulate the activity of a number of proteins 
through post-translational modification.125 The ratio of GSH:GSSG is a useful indicator of 
cellular redox status and oxidative stress, with smaller values indicating an oxidative shift and 
larger values signifying a more reduced cellular state.117  
Glutathione depletion by L-buthionine-[S,R]-sulfoximine 
Attempts to evaluate the cellular redox status and the potential for cytoprotection by 
endogenous antioxidants due to various stressors has been attempted through GSH depletion 
both in cell culture and in animal models.82, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135, 136, 137, 138, 139 
The vast body of literature on this biomolecule highlights its varied roles in many cellular 
functions. A large proportion of research literature has focused on chronic depletion of GSH to 
elucidate the degree of protection its presence confers upon cells. The most common depletion 
method uses specific inhibitors of elements of the γ-glutamyl cycle. A safe, established and 
effective method of obtaining this depleted model is use of the drug L-buthionine-[S,R]-
sulfoximine (BSO), an inhibitor of γ-GCS.140 Through inhibition of synthesis of GSH, levels 
are gradually depleted in almost all organ compartments in the body. BSO has been used to 
reliably deplete GSH in several tissues, including liver,139, 140 kidney,139, 140 pancreas,139, 140 
skeletal muscle,139, 140 brain139, 141 and heart.82, 139  
Glutathione and apoptotic signalling 
There is compelling evidence that intracellular glutathione is depleted acutely during apoptosis 
as part of death signal propagation, which may be effective in shifting the oxidative balance 
without necessarily causing overproduction of ROS.129, 142 This local GSH depletion has been 
attributed to GSH extrusion from the cell during apoptosis30, 126, 143, 144 or as a result of 
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cleavage of enzymes involved in GSH synthesis.145 For instance, Jurkat cells, a T lymphocyte 
cell line, experience rapid intracellular depletion of GSH due to stimulation of extracellular 
death receptors by Fas/APO-1-activating antibody.144 Apoptosis induced by a variety of agents 
in thymocytes leads to disruption of the mitochondrial membrane potential, production of 
ROS, and depletion of GSH in the early stages of apoptosis.146 Further evidence for the 
relationship between cellular GSH levels and mitochondrial membrane potential fluctuations 
comes from studies using bongkrekic acid (BA), an inhibitor of the adenine nucleotide 
transporter (ANT) located on the inner mitochondrial membrane. ANT is one of the proposed 
channels involved in mitochondrial permeability transition (MPT), leading to release of pro-
apoptotic factors into the cytosol.38 BA has been shown to inhibit several apoptotic events 
associated with MPT, such as generation of ROS, DNA fragmentation, and local depletion of 
GSH.147 Cells overexpressing anti-apoptotic Bcl-xL are protected from GSH extrusion when 
exposed to an apoptotic challenge, but similar cells overexpressing pro-apoptotic Bax 
experience a significant loss of GSH prior to apoptosis onset, highlighting the cooperation 
between GSH and Bcl-xL in promoting cell survival.126 Activation of plasma membrane GSH 
transporters in hepatic cells can be increased by treatment with extrinsic pathway death 
ligands,143 while Bcl-2 overexpression in HeLa cells helps to conserve intracellular GSH levels 
by inhibiting a methionine-dependent efflux pump.148 Bcl-2 overexpression in other cell lines, 
such as the GT1-7 hypothalamic line, has shown similar anti-apoptotic effects when 
glutathione depletion is induced. In fact, basal GSH levels have been reported up to 3 orders of 
magnitude higher in Bcl-2 overexpressors compared to controls, an effect that is conserved 
even when BSO is used to deplete intracellular GSH stores.149 Exposure of apoptosis-resistant 
lymphoma cells to cysteine/methionine-free culture media restores apoptotic sensitivity, 
19 
 
comparable to the irradiation-sensitive lymphoma cell line; this effect is mediated by a drop in 
intracellular GSH levels.150 Lastly, Bcl-2 overexpression has been shown to cause localization 
of GSH to the nucleus, leading to prevention of caspase activation and subsequent apoptotic 
death.151 In addition to the above links between apoptotic signalling and GSH, caspase-3 has 
been shown to mediate cleavage of the catalytic subunit of γ-GCS, resulting in depletion of 
GSH due to loss of enzyme activity and de novo GSH synthesis.145  
Use of the BSO-induced glutathione depletion model has shed light on the interaction 
between intracellular GSH levels and risk of apoptotic events. For instance, apoptotic 
signalling is associated with increased ROS production due to glutathione depletion by BSO in 
a B cell lymphoma line.152 Mitochondrial permeability transition was shown to be activated in 
BSO-treated HL-60 cells, a human leukemia cell line; this effect was mediated by 
mitochondrial ROS generation.153 Chronic glutathione depletion through an engineered cell 
line has been shown to increase apoptotic markers in as little as 48 hours.154 In addition, severe 
mitochondrial damage has been attributed to BSO-induced GSH depletion. In mitochondria 
isolated from the brains of newborn rats, GSH depletion leads to mitochondrial swelling and 
degeneration.141 BSO has also been shown to be effective in inducing estrogen-mediated 
apoptosis in a human breast cancer cell line characterized by its high intracellular GSH 
stores.155  
Alternatively, increasing GSH levels as a protective mechanism against apoptosis has 
shown some success. For example, GSH has been shown to prolong survival in cancer cell 
lines.128 Mice fed a sulphur amino-acid enriched diet (supplemented with 1% L-cysteine and 
1% GSH) experienced a 63% increase in hepatic GSH levels.52 These animals were 
subsequently injected with an antagonistic anti-Fas antibody and showed preserved 
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GSSG:GSH ratio, prevention of mitochondrial permeabilization and hepatic apoptosis 
compared to age-matched controls fed a normal chow diet.52 Activated human T cells display 
an apoptosis-resistant phenotype upon exposure to Fas when supplemented with glutathione 
monoesters or N-acetylcysteine (NAC; a thiol antioxidant and precursor to GSH). This effect 
was completely abolished when cells were subjected to BSO-induced GSH depletion.156 
Collectively, this data demonstrate the potentially protective relationship between intracellular 
GSH levels and apoptotic signalling, wherein maintenance of thiol levels results in an anti-
apoptotic phenotype.  
Purpose 
There are established links between oxidative stress and apoptosis, along with the consistent 
observation of increased oxidative stress as a result of both aging and glutathione depletion by 
BSO. Studies on the effect of GSH depletion on apoptosis have been carried out in a variety of 
tissues; however, little is known about these effects in skeletal muscle. Therefore, the purpose 
of the present study was to examine the role of glutathione in skeletal muscle apoptotic 
signalling, with particular emphasis on muscles composed of different fiber types. Antioxidant 
redox status changes, as well as shifts in antioxidant capacity were examined in soleus, a 
predominantly slow-twitch, oxidative muscle, and contrasted to the white portion of the 
gastrocnemius, a predominantly fast-twitch glycolytic muscle. Apoptotic protein expression 
and DNA fragmentation were also determined in these two muscle types. In addition, the 
effects of aging on skeletal muscle apoptosis, in combination with the oxidative challenge of 





The primary aim of the present study is to investigate the role of GSH depletion in apoptotic 
signalling in skeletal muscle. Given the unclear relationship between apoptotic signalling and 
GSH in skeletal muscle, a GSH depletion model will be used to better understand the 
importance of antioxidant status in apoptotic signalling in this tissue. Soleus and white portions 
of the gastrocnemius muscle have been chosen for analysis due to their established differences 
in oxidative potential and relatively pure fiber type composition (Soleus predominantly type I, 
WG predominantly type IIB). A secondary aim of this study is to elucidate the effect of 
advancing age on apoptotic signalling in GSH-depleted and GSH-intact skeletal muscle. There 
is an established link between apoptotic signalling and aging; however, the effect of GSH 
depletion on apoptosis in skeletal muscle of older animals is currently unclear. 
Hypotheses 
The hypotheses of the current work are as follows: 
1. BSO treatment will decrease muscle GSH and increase muscle ROS production in both 
slow and fast skeletal muscle types. This effect will be further amplified in older 
animals. 
 
2. Skeletal muscle from older animals will experience higher levels of oxidative stress 





3. In addition, upregulation of antioxidant enzymes will be observed primarily in the older 
animal groups, with the highest values seen in the old BSO-treated group. 
 
4. The hypothesized increases in oxidative stress will lead to increased markers of 
apoptotic signaling in both soleus (slow) and white gastrocnemius (fast) muscle, with 
the highest increases observed in older, BSO-treated animals. 
 
5. Levels of apoptotic markers will be increased in SOL compared to WG, as there are 
established differences in basal apoptotic expression in these muscle types. This will be 
















Male Sprague-Dawley rats were obtained from an in-house breeding colony (University of 
Waterloo, Waterloo, ON) for inclusion in this study. Two age groups were examined: a 
“young” group made up of adult-aged animals (34.85 ± 0.14 weeks; n=24) and an “old” group 
consisting of approximately middle-aged animals (69.11 ± 0.74 weeks; n=24). Rats were 
housed in a controlled environment at constant air temperature (20-21˚C) and humidity (~50%) 
on a 12h:12h reversed light/dark cycle. Standard Teklad 22/5 rodent chow (Harlan, WI) was 
provided, with intake monitored daily. All animal care procedures were approved by the 
University of Waterloo Animal Care Committee. 
BSO treatment 
The drug L-buthionine-[S,R]-sulfoximine (BSO; BioShop Canada Inc.), a specific γ-
glutamylcysteine synthetase inhibitor, was used to deplete glutathione levels. The young and 
old rats were subdivided into control (CON) and BSO-treated (BSO) groups, resulting in four 
experimental groups: Young CON (n=12), Young BSO (n=12), Old CON (n=11) and Old BSO 
(n=13). Control animals were provided regular drinking water while BSO-treated animals were 
given water containing 30mM BSO ad libitum for 10 consecutive days, with intake recorded 
daily. Water was changed every 2 days, due to the limited half-life of the BSO drug. Body 
weight of all animals was determined prior to BSO administration as well as after the 10 day 





At the end of the 10 day drug treatment, the BSO-treated rats and age-matched controls were 
anesthetized with sodium pentobarbital (90-100mg/kg body weight) and sacrificed by removal 
of the heart. Soleus and white portions of the gastrocnemius muscle were quickly isolated. The 
majority of excised muscle was quickly snap frozen in liquid nitrogen and stored at -80˚C for 
further biochemical analyses. A small portion of the muscle belly of each muscle type was 
covered in Tissue-Tek Optimal Cutting Temperature medium (Sakura Finetek, USA), quickly 
frozen in liquid nitrogen-cooled isopentane, and stored at -80˚C for immunohistochemical 
analyses. 
Immunoblot analyses and subcellular fractionation 
For whole muscle homogenates, skeletal muscle (~20-25mg) was homogenized in 19 volumes 
of ice-cold muscle lysis buffer (20mM HEPES, 10mM NaCl, 1.5mM MgCl2, 1mM DTT, 20% 
glycerol and 0.1% Triton X100; pH 7.4) with protease inhibitors (Complete Cocktail; Roche 
Diagnostics) using a glass homogenizer. Homogenates were then centrifuged at 1000 x g for 10 
minutes at 4˚C, the supernatant was collected, and total protein was determined by the BCA 
protein assay. 
Subcellular fractions of muscle were prepared by differential centrifugation (see Figure 
3). Briefly, skeletal muscle (45mg for soleus, 60-65mg for white gastrocnemius) was 
homogenized by hand in 19 volumes of ice-cold mitochondrial isolation buffer (250mM 
sucrose, 20mM HEPES, 10mM KCl, 1mM EDTA, 1mM EGTA, 1mM DTT; pH 7.4) with 
protease inhibitors (Complete Cocktail; Roche Diagnostics) using a glass homogenizer. 
Homogenates were centrifuged at 800 x g at 4°C for 10 minutes, yielding a pellet (P1) and 
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supernatant (S1). The resulting S1 fraction was spun at 800 x g at 4°C for an additional 10 
minutes to remove any residual debris and the resulting supernatant transferred to a new tube 
(S2). The S2 fraction was then spun at 20,800 x g at 4°C for 20 minutes to yield a pellet 
containing the mitochondrial fraction (M1) and a supernatant corresponding to the cytosolic 
fraction (C1). The M1 pellet was washed twice by adding mitochondrial isolation buffer and 
centrifuged at 20,800 x g at 4°C for 20 minutes. The resulting pellet was considered the 
enriched mitochondrial fraction. The C1 supernatant was re-spun two additional times at 
20,800 x g at 4°C for 20 minutes to remove any residual mitochondria and debris, resulting in a 
cytosolic-enriched fraction. The P1 pellet obtained from the first spin of the whole muscle 
homogenate was washed with mitochondrial isolation buffer and spun at 800 x g at 4°C for 10 
minutes three additional times. The remaining pellet at this stage was combined with 200 µL of 
muscle lysis buffer and 27.7 µL of 5M NaCl, and rotated for 1 hour at 4°C. The samples were 
then centrifuged at 20,800 x g at 4°C for 15 minutes, with the resultant supernatant kept as the 
nuclear-enriched fraction. Total protein concentration was determined for each fraction by the 
BCA protein assay and immunoblots performed to verify the purity of fractions using the 
following primary antibodies: rabbit polyclonal anti-histone H2B (Cell Signaling Technology) 
for the nuclear fraction, rabbit polyclonal anti-copper zinc superoxide dismutase (CuZnSOD) 
(Stressgen Bioreagents) for the cytosolic fraction, and goat polyclonal anti-adenine nucleotide 
translocase (ANT) (Santa Cruz Biotechnology) for the mitochondrial fraction. Samples were 
then stored at -80°C for further immunoblot analysis. 
Equal amounts of protein were loaded in duplicate and electrophoresed on 12% or 15% 
SDS-PAGE gels, transferred onto PVDF membrane (Bio-Rad Laboratories), and blocked 
overnight with 5% milk in Tris-Buffered Saline with 0.1% Tween (TBS-T) at 4˚C. Membranes 
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with whole homogenate samples were incubated at room temperature for 1 hour with the 
following primary antibodies: mouse monoclonal anti-apoptosis inducing factor (AIF), rabbit 
polyclonal anti-apoptosis repressor with caspase recruitment domain (ARC), rabbit polyclonal 
anti-Bax (Santa Cruz Biotechnology); rabbit polyclonal anti-CuZnSOD, mouse monoclonal 
anti-heat shock protein 70 (Hsp70), rabbit polyclonal anti-manganese superoxide dismutase 
(MnSOD), rabbit polyclonal anti-second mitochondrial activator of caspases (Smac) (Stressgen 
Bioreagents); and rabbit polyclonal anti-catalase (Sigma-Aldrich). For detection of Bcl-2 and 
4HNE in whole homogenates, membranes were blocked with 5% TBS-T at room temperature 
for 1 hour then incubated with either a mouse monoclonal anti-Bcl-2 primary antibody (Santa 
Cruz Biotechnology) or a rabbit polyclonal anti-4HNE primary antibody (Abcam) for 1-2 
hours at room temperature, followed by further incubation at 4ºC overnight. The subcellular 
fractions obtained were also electrophoresed and blocked as specified above, with different 
proteins examined in the various fractions. AIF detection was performed in both the nuclear 
and cytosolic fractions in both tissues, and in mitochondrial fractions of WG only (due to 
limited sample), while Smac and cytochrome c (mouse monoclonal primary; Santa Cruz 
Biotechnology) were examined in the cytosolic fraction of SOL and WG as an indirect marker 
of mitochondrial release of these proteins. Membranes were then washed with TBS-T and 
incubated with the appropriate species-specific horseradish peroxidase (HRP)-conjugated 
secondary antibody (Santa Cruz Biotechnology) for 1 hour at room temperature, washed, and 
visualized using the Amersham Enhanced Chemiluminescence Western Blotting detection 
reagents (GE Healthcare) and the ChemiGenius 2 Bio-Imaging System (Syngene). The only 
deviations from these steps was in the detection of Bcl-2, whereby 2 hours of secondary 
antibody incubation was used in combination with the Amersham ECL Plus detection reagents 
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(GE Healthcare). The approximate molecular weight for each protein of interest was estimated 
using Precision Plus Protein WesternC Standards in conjunction with Precision Protein 
Streptactin HRP Conjugate (BioRad Laboratories). Equal loading and quality of protein 
transfer was evaluated by Ponceau S staining (Sigma-Aldrich). Protein levels are expressed as 








Reduced glutathione (GSH) and oxidized glutathione (GSSG) levels were determined by high-
performance liquid chromatography (HPLC).157 Briefly, 20-25 mg of muscle tissue was 
homogenized on ice in 10 volumes of 2mM phenanthroline in 7% perchloric acid using a glass 
homogenizer. After a brief incubation on ice, samples were centrifuged at 1000 x g for 10 
minutes at 4˚C. A portion of the supernatant (125μL) was removed, treated with 5μL of 0.4 M 
iodoacetic acid, and neutralized with excess NaHCO2. Samples were then incubated in the dark 
at room temperature for 1 hour, after which time they were treated with 1μL 1-fluoro-2,4-
dinitrobenzene (1.5mL in 98.5mL absolute ethanol), and further incubated in the dark for 8 
hours. A 25μL aliquot of each sample was run on a Waters Alliance 2695 system using a 
Varian (Rainin) Microsorb 5μM amino (25cm x 4.5cm) column at room temperature for 35 
minutes with a flow rate of 1mL/min, and detected at 350 nm. 
Reactive Oxygen Species generation 
Reactive oxygen species (ROS) generation was determined using 
2’,7’dichlorohydrofluorescein-diacetate (DCFH-DA) as previously performed.9, 107 DCFH-DA 
is hydrolyzed by intracellular esterases to yield nonfluorescent DCFH, which is oxidized to the 
highly fluorescent compound DCF as a result of ROS exposure. Briefly, ~10 mg of muscle 
tissue was homogenized in ice-cold Phosphate-Buffered Saline (PBS; pH 7.4) using a glass 
homogenizer. Duplicates of whole muscle homogenate were pre-incubated with the ROS 
scavenger Tiron (1mM) as a negative control, or left untreated. Samples were then incubated in 
the dark with 5μM DCFH-DA (Invitrogen) at 37˚C. Fluorescence was measured every 15 
minutes for 2 hours using a SPECTRAmax GEMINI XS microplate spectrofluorometer 
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(Molecular Devices) with excitation and emission wavelengths of 490 nm and 525 nm, 
respectively. Fluorescence intensity was normalized to total protein content and expressed as 
AU per mg protein. 
Caspase proteolytic enzyme activity 
The enzyme activity for caspase-3, caspase-8, and caspase-9 was determined 
spectrofluorimetrically in muscle homogenate using the fluorescent substrates Ac-DEVD-
AMC, Ac-IETD-AMC, and Ac-LEHD-AMC (Enzo Life Sciences), respectively. Briefly, 12-
15mg of tissue was homogenized in ice-cold muscle lysis buffer, without protease inhibitors, 
and centrifuged at 1000 x g for 10 minutes at 4˚C. Tissue supernatants were then incubated 
with the appropriate substrate at room temperature for 2 hours. Fluorescence was measured 
every 15 minutes using a SPECTRAmax Gemini XS microplate spectrofluorometer (Molecular 
Devices) with excitation and emission wavelengths of 360 nm and 440 nm, respectively. In 
control experiments, caspase substrates were incubated with either human recombinant active 
caspase-3 (Enzo Life Sciences), caspase-8 (Sigma-Aldrich), or caspase-9 (Enzo Life Sciences). 
In all cases, a strong fluorescent signal was obtained, indicating the specificity of the selected 
substrates. In addition, incubation of active recombinant enzymes as well as muscle samples 
with inhibitors for caspase-3 (Ac-DEVD-CHO; Enzo Life Sciences), caspase-8 (Ac-IETD-
CHO; Sigma-Aldrich), and caspase-9 (Ac-LEHD-CHO; Enzo Life Sciences) completely 
inhibited the fluorescent signal observed. Caspase activity was normalized to total protein 





DNA fragmentation assay 
Cytoplasmic histone-associated mono- and oligonucleosomes (ie. from fragmented DNA) were 
determined using the Cell Death Detection ELISAPLUS Kit (Roche Diagnostics) according to 
the manufacturer’s instructions. Briefly, 5-7 mg of muscle tissue was homogenized in the lysis 
buffer provided, incubated for 30 minutes at room temperature and centrifuged at 200 x g for 
10 minutes at room temperature. A 20 μL aliquot of supernatant was incubated with 80 μL of 
anti-histone-biotin/anti-DNA-peroxidase reagent in a streptavidin-coated microplate for 2 
hours at room temperature with gentle shaking (~300 rpm).  The solution was then aspirated 
from each well, washed 3 times with the incubation buffer provided in the kit, replaced with 
100 μL of 2,2’-azino-bis(3-ethylbenzthiazoline-6-sulphonic acid) (ABTS) substrate solution 
and incubated for a further 30 minutes at room temperature. Absorbance measurements were 
taken every 5 minutes using a SPECTRAmax Plus spectrophotometer (Molecular Devices) at 
405 nm and 490 nm. A control sample consisting of a DNA-histone complex was included to 
confirm a positive signal for DNA fragmentation. Absorbance was normalized to total protein 
content and expressed as AU per mg protein. 
Immunohistochemical analyses 
Lipid peroxidation due to oxidative stress 
Skeletal muscle cross-sections (10 µm) were obtained using a Shandon Cryotome SME 
(Thermo Electron Corp.). Muscle cross-sections were examined for lipid peroxidation using 
immunofluorescence staining for 4-hydroxynonenal (4-HNE) content. 4-HNE is the primary 
α,β-unsaturated hydroxyalkenal produced in cells as a result of oxidative insult;95 in particular, 
expression of this peroxidation product has been observed in skeletal muscle exposed to 
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oxidative stress158. Frozen slides were thawed, air dried and fixed in 4% paraformaldehyde. 
Next, slides were blocked in 5% goat serum for 30 minutes, and then incubated for 1 hour in a 
humidified chamber with the same rabbit polyclonal anti-4-HNE primary antibody (AbCam) 
used for immunoblot analysis. Sections were washed in PBS and then incubated in the dark in 
a humidified chamber with a goat anti-rabbit IgG-FITC secondary antibody (Santa Cruz 
Biotechnology) for 1 hour, washed in PBS, and mounted in ProLong Gold Antifade Reagent 
(Invitrogen). Sections were visualized using a Zeiss Axio Observer Z1 structured-illumination 
fluorescent microscope equipped with an AxioCam HRm camera and associated AxioVision 
4.7 imaging software (Carl Zeiss). 
ARC staining 
Muscle cross-sections were thawed and air dried, then fixed in 100% acetone at 4°C for 10 
minutes and air dried for an additional 5 minutes. They were washed in PBS and subsequently 
permeabilized in 0.5% Triton X-100 for 5 minutes. After washing, 0.6% hydrogen peroxide 
(H2O2) was applied to sections for 10 minutes to quench endogenous peroxidase activity. 
Sections were then washed and blocked with 5% goat serum in PBS for 30 minutes in a 
humidified chamber, and subsequently incubated for 1 hour with the same rabbit polyclonal 
anti-ARC antibody (Santa Cruz Biotechnology) used for immunoblot analysis. Sections were 
then washed and incubated with an anti-rabbit IgG biotinylated secondary antibody (Vector 
Laboratories) for 1 hour, washed, and incubated with ABC Reagent for 30 minutes (Vector 
Laboratories). After another wash, the NovaRED peroxidase substrate kit (Vector 
Laboratories) was used, which produces a red precipitate at the target staining areas; the stain 
was left on the slides for 13-15 minutes. Slides were rinsed with dH2O to remove residual stain 
and washed once more in PBS before being mounted in glycerol gel medium and visualized 
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using a Nikon Eclipse 50i light microscope with a PixelLink Camera and associated imaging 
software. 
Data analysis 
Data is represented as means ± standard error of the mean for each experimental group. Group 
comparisons were conducted using a 2 X 2 ANOVA followed by Tukey post hoc analysis 
where appropriate. For comparison of approximate drug intake between young and old BSO-
treated animals, a Student’s t-test was performed. Except where otherwise indicated, data were 
normalized to the Young CON group for the muscle of interest. Statistical significance was set 



















Anthropometric, water and food intake data 
Anthropometric data, along with food and water intake for all experimental animals, can be 
found in Table 1. As expected, there was a significant difference in age (p<0.01) between the 
“young” and “old” groups (34.85 ± 0.14 versus 69.11 ± 0.74 weeks). Though there was no 
statistically significant effect for age in terms of water intake, the young groups consumed 10% 
more water than their older counterparts, on average. The interaction term for water intake was 
significant (p<0.01), indicating that the Young BSO animals consumed up to 34% more water 
than the Old BSO group during the 10-day treatment period. A significant age-related decrease 
in approximate BSO dose was seen, from 3.74x10-3 ± 0.24x10-3 mmol/g/day in Young BSO to 
2.33x10-3 ± 0.14x10-3 mmol/g/day in Old BSO. The Old BSO group also consumed 
significantly less food than all other groups, as assessed by the interaction term (p<0.05) for 
this measure. Additionally, BSO dose was inversely correlated with post-treatment body 
weight (r=-0.789, p<0.001) as well as kidney weight (r=-0.743, p<0.001), whereby higher BSO 
doses corresponded to lower body and kidney weights. There was also a significant (p<0.01) 
age-related increase in kidney weight compared to younger animals. 
Prior to BSO treatment, a significant (p<0.01) main effect for age was observed in pre-
treatment body weight, whereby old animals weighed more than their younger counterparts. A 
similar age-related effect persisted after treatment; in addition, BSO-treated animals 
experienced significant (p<0.01) decreases in body weight compared to age-matched controls 
as assessed by the average change in weight from pre- to post-treatment. A main effect for age 
(p<0.01) was also observed for this measure, whereby older animals lost significantly more 
weight than younger animals over the course of the treatment period. Lastly, muscle cross-
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sectional area, used to assess possible losses of muscle mass in place of the muscle wet weight, 
showed a main effect (p<0.05) for age in SOL, with 15% higher values observed in old 
compared to young animals. WG tissue also displayed a significant main effect (p<0.05) for 
age, but older animals had 16% lower muscle cross-sectional area than their younger 
counterparts. 
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BSO treatment alters glutathione content 
Reduced glutathione (GSH) content, as measured by HPLC, showed a significant (p<0.05) 
main effect for drug treatment, as GSH was significantly decreased in SOL and WG tissues 
compared to age-matched controls. SOL GSH decreased 89% from controls to BSO-treated 
animals (Figure 4), while in WG GSH similarly decreased 96% (Figure 5). Glutathione 
disulfide (GSSG) content followed a similar pattern to that observed for GSH. Namely, GSSG 
levels were not affected by age in either tissue but were decreased 89% (p<0.001) in WG due 
to BSO treatment compared to controls (Figure 5). There was a significant interaction (p<0.05) 
effect in SOL GSSG, whereby both BSO groups were decreased compared to the Young CON 
group. Additionally, the Young CON group was decreased compared to the Old CON’s 
(Figure 4).  
 
Figure 4: GSH and GSSG levels in soleus (SOL) muscle; values are presented as means ± SEM. 
** indicates main effect for BSO (p<0.001); @ significantly different than Old CON (p<0.05); + significantly 





Figure 5: GSH and GSSG levels in white gastrocnemius (WG) muscle; values are presented as means ± SEM.  
** indicates main effect for BSO (p<0.001). 
 
BSO treatment also significantly impacted the GSH:GSSG ratio, a commonly-used 
indicator of cellular redox status. BSO-treated groups were significantly (p<0.05) decreased by 
62% in the WG tissue compared to age matched controls. A significant interaction (p<0.05) 
was observed in the SOL, whereby both the Young BSO and Old BSO groups were 
significantly reduced compared to the controls, respectively (Figure 6). 
 
Figure 6: GSH:GSSG ratios in WG and SOL tissues; values are presented as means ±SEM.  




BSO treatment leads to increased ROS production only in SOL in the absence of similar effects 
on lipid peroxidation 
ROS production was determined in muscle homogenate by measuring DCFH oxidation. BSO 
treatment led to significantly (p<0.05) increased ROS production in SOL muscles compared to 
age-matched controls (Figure 7). ROS production was not different between groups in WG 
muscle (Figure 7).  
 
Figure 7: ROS production in SOL and WG muscle; all values are represented as arbitrary fluorescent units per 
mg protein. ** indicates main effect of BSO (p<0.05). 
 
 In contrast to the observed increase in ROS production, 4 hydroxy-2-nonenal (4HNE) 
levels were not significantly different between groups in both WG and SOL as measured by 
immunoblot analysis (Figure 8). There was a nonsignificant trend (p=0.097) toward a 37% 
decrease in 4HNE protein levels in BSO animals compared to controls in SOL. 
Immunofluorescence analysis did, however, show a 15% decrease (p<0.05) in 4HNE staining 
in BSO-treated SOL tissue compared to age-matched controls (Figure 9, panels B and C). 
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Figure 12: Relative activities for caspases-3, -8, and -9 in SOL muscle; all values are normalized to Young CON 
group and expressed as means ± SEM. * indicates main effect for AGE (p<0.05). 
 
 
Figure 13: Relative activities for caspases-3, -8, and -9 in WG muscle; all values are normalized to Young CON 







Whole tissue apoptosis-related protein levels demonstrate age-related variations independent 
of BSO treatment status 
Several apoptosis-related proteins were examined in SOL and WG by immunoblot analysis. 
ARC protein content in SOL was decreased 28% in older animals compared to their younger 
counterparts (p<0.05) while SOL Hsp70 increased 18% in these same animals (p<0.05) (Figure 
14). Immunohistochemical analysis was also performed for ARC, confirming the above results. 
Densitometric IHC analysis revealed a 20% decrease in intensity of staining in older SOL 
muscle cross sections in relation to younger animals (Figure 16, panels B and C). A 
significantly (p<0.05) increased staining intensity in SOL muscle cross-sections was observed 
compared to WG muscle, with all groups displaying up to a 2-fold higher staining (Figure 16, 
panels A and B). The only exception was the Old BSO group, whereby the SOL and WG 
staining intensities were not significantly different (Figure 16 panel C). Lastly, SOL Bcl-2 
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BSO treatment leads to significant DNA fragmentation in WG with little effect in SOL 
DNA fragmentation, one of the hallmark events in apoptosis, was quantified using a Cell Death 
Detection ELISA. Average DNA fragmentation was increased 38% (p<0.05) in BSO-treated 
animals in WG tissue and 11% (p<0.05) in SOL tissue (Figure 23). No age-related changes in 
DNA fragmentation were observed in either tissue. In addition, DNA fragmentation values 
were 12-fold higher in SOL tissue compared to WG (p<0.05; Figure 23). 
 
Figure 23: Quantification of DNA fragmentation in SOL and WG tissues using the Cell Death Detection 
ELISAPLUS. Data shown are relative optical densities normalized to WG Young CON; values are presented as 
means ± SEM. **indicates the main effect for BSO treatment (p<0.05), detected in both SOL and WG tissues; # 











Effect of BSO treatment and age on cellular thiol levels and anthropometric indicators 
As reported elsewhere,132, 136, 138, 139, 152, 159, 160, 161 BSO treatment leads to significant 
reductions in GSH content. In the present work, SOL GSH levels were decreased by 89% 
compared to age-matched controls, while WG GSH levels were decreased by 96% in the BSO-
treated groups. GSH levels were not affected by age in SOL or WG. GSSG levels were 
decreased as a result of BSO treatment in WG and SOL. Interestingly, in SOL, GSSG levels in 
the Old CON group were 29% higher than in the Young CON group. GSSG levels were not 
different due to age in WG. Owing to the fact that GSSG is the oxidized form of GSH, its 
levels are shown to increase in situations of oxidative stress such as aging.76 The loss of GSSG 
observed in this study is primarily due to the severe BSO-induced reduction in GSH 
synthesis;137 with very little GSH remaining in the cells, the levels of GSSG are decreased 
accordingly. There is also some evidence that GSSG can be released from the cell in response 
to oxidative stress.162 In other words, when there is less of the oxidized glutathione form 
(GSSG) present in the cell, the overall GSH:GSSG ratio will be higher. Higher GSH:GSSG 
ratios are generally indicative of a more reducing environment, which is the “usual” state of the 
cell.163 In the present work, these ratios were significantly decreased in SOL and WG as a 
result of BSO treatment, indicating a shift towards a more oxidative cellular environment.  
 Interestingly, anthropometric measures were also altered in response to BSO treatment. 
Animals receiving BSO had significantly lower post-treatment body weights than age-matched 
controls and experienced greater weight loss over the course of the experimental period. 
Additionally, there were negative correlations between BSO dose (calculated based on water 
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intake) and post-treatment body weight and kidney weight. The inverse dose-kidney weight 
relationship may be indicative of potential drug-induced toxicity, as changes in kidney weight 
are a commonly-used marker of toxicity.164 It is possible that potential drug toxicity was a 
result of the dosage used. In this study, 30mM BSO was used when a more typical dose, as 
cited in the literature, is 20mM or less.131, 137, 138, 140 However, there is some debate as to 
whether the 30mM BSO dose is in fact toxic. Some investigators have observed decreased liver 
weights, another index of potential drug toxicity, when using the 30mM dose over 14 days139 
while others have observed little to no toxic effects.165, 166 Tissue damage or other markers of 
toxicity, such as change in liver weight or liver enzyme activity, would have been helpful to 
further elucidate the potential toxic effects of BSO; however, these were not performed. 
Increasing age had an impact on food intake and anthropometric measures, particularly those 
related to body and organ weight. Older animals consumed less food than their younger 
counterparts, with the overall lowest food intake seen in the Old BSO group. Body weight was 
higher in older animals both before and after the BSO treatment, with greater changes in body 
weight over the 10-day experimental period observed in the old animals compared to the 
young. Kidney weight was also increased with age. 
 Measurements of muscle wet weight are typically performed in comparative studies 
such as this, but unfortunately were not carried out here. In place of this, muscle cross-
sectional area (CSA) was used as an approximate indicator of muscle size. Although muscle 
weights would have been useful, we were interested in studying the SOL and WG muscles 
specifically. Tissue weight for the SOL would have been easily obtained without any major 
limitations; however, accurate weight for WG would have been problematic as the isolation of 
this muscle is somewhat subjective. Measurement of fiber CSA is one way to overcome this 
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limitation. Muscle wet weight and CSA are typically examined together, particularly in studies 
focused on aging or muscle atrophy and are nicely correlated.71 In the WG, CSA was decreased 
by 16% with age, while in aged SOL, muscle CSA increased by 15%. This selective muscle 
fiber atrophy is a common observation in experimental aging models. Human gastrocnemius 
muscle shows decreased type IIA and IIB fiber CSA with age, resulting in an overall decreased 
muscle size.167 In addition, the CSA of type I fibers has been shown to vary little, if at all, with 
age.167 The differences observed between SOL and WG are interesting but may reflect 
differences in muscle recruitment. The soleus is a postural muscle composed of primarily type 
I fibers that is continually recruited, whereas the WG is composed of predominantly type IIB 
fibers that have a higher recruitment threshold.168 Therefore, SOL muscle of aged animals may 
have experienced greater recruitment than WG, coupled with the increased load (body weight), 
which could have led to selective muscle fiber hypertrophy in the SOL. No BSO-induced 
changes in fiber CSA area were observed in this study. 
Effect of BSO treatment and age on markers of oxidative stress and antioxidant content in WG 
To further evaluate the effect of age and BSO on the redox state in the muscle, ROS 
generation, 4HNE levels and several antioxidant proteins (catalase, MnSOD, CuZnSOD) were 
measured. In WG, no significant differences in ROS production (as determined by DCFH 
oxidation) in whole muscle homogenate were observed due to BSO treatment or age. Similarly, 
4HNE levels (a measure of lipid peroxidation) were unchanged in the WG across all groups. 
Furthermore, there were no significant changes observed in the protein content of MnSOD and 
CuZnSOD irrespective of age or BSO treatment in WG. In contrast, catalase protein content 
was increased on average by 1.5-fold in older animals and by 1.7-fold in WG of BSO-treated 
animals. This upregulation, particularly in the BSO-treated group, is noteworthy due to the 
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similarities between the methods of action of catalase and thiol-dependent glutathione 
peroxidase (GPx). Catalase is a potent detoxifier of cellular H2O2.117 GPx is another detoxifier 
of cellular H2O2 that consumes 2 GSH molecules in this process.29 Several studies suggest that 
the activation of these antioxidant enzyme systems may differ depending on the oxidative 
stress signal, even though they accomplish similar functions in the cell. For example, paraquat 
(a potent ROS producer) has been shown to deplete GSH levels while simultaneously 
increasing SOD and catalase expression and activity without affecting GPx activity.169 The 
authors of this work postulate that the depleted GSH levels result in the lack of change in GPx 
activity, resulting in a reliance on other antioxidant enzymes to combat the oxidative stress.169 
It has also been shown that catalase and GPx activities vary differentially depending on cellular 
localization of the oxidative stress, with GPx responsible for H2O2 generated in the 
endoplasmic reticulum and catalase handling peroxisomal H2O2.170 Therefore, a compensatory 
increase in catalase likely occurred as a result of GSH depletion in WG. A compensatory 
antioxidant upregulation is frequently observed with advancing age, consisting of elevated 
activity of MnSOD and catalase77, 171 as well as CuZnSOD and GPx.171 This upregulated 
response has also been observed with BSO treatment, consisting of increased activity and 
content of SOD’s in certain tissues such as rat heart and aorta.82, 159 Lastly, others have shown 
BSO does indeed lead to decreased activity of GPx1.82 It is possible that the upregulation in 
catalase observed with BSO and age was sufficient to maintain ROS and lipid peroxidation at 
levels similar to the Young CON animals. 
Effect of BSO treatment and age on markers of oxidative stress and antioxidant content in SOL 
In contrast to the WG muscle, SOL displayed a 20% increase in ROS production due to BSO 
treatment with no independent effect of age. The higher ROS in SOL of BSO-treated animals 
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with no observable difference in WG may be a consequence of the different ROS sources 
between tissues. It is well-documented that SOL has a high mitochondrial content compared to 
WG.172, 173, 174 For example, markers of mitochondrial content such as citrate synthase activity 
are 2.6-fold higher in SOL compared to WG,174 while succinate dehydrogenase activity is 2.2-
fold higher in SOL.173 Results from our lab are consistent with these findings (Bloemberg & 
Quadrilatero, 2010). Other markers of mitochondrial density, such as PGC-1α protein levels, 
are elevated in SOL compared to WG in the basal state.172 In addition, mitochondria are a 
significant source of ROS,86, 87, 89 meaning they may require increased defense against 
oxidative damage. As such, there is a distinct mitochondrial pool of GSH134 and work in our 
lab has shown that GSH is depleted in isolated mitochondria of BSO-treated animals (Dam et 
al., 2010). Accordingly, the higher ROS in the SOL of BSO-treated animals could be attributed 
to elevated ROS production from sources such as the mitochondria. In contrast, there were no 
age effects seen in ROS production. The lack of an age effect in SOL and WG may be due to 
the fact that the aged animals used in this study (ie. 17 months old) were not as old as those 
typically used in aging research (24-36 months old). This is supported by work conducted in 
rat muscle examining measures of oxidative protein damage in young (5 months), adult (13 
months) and old (24 months) animals.175 Oxidative damage markers such as protein carbonyls 
and nitrotyrosine were only increased in the oldest compared to the youngest group, with no 
elevation in the adult age group.175 These results may indicate that the mid-range age of our 
“old” animals may not have been sufficient to observe the usual age-related changes in 
oxidative stress. 
SOL 4HNE levels showed a slight decrease in BSO animals compared to controls with 
no age-related effect observed. This result conflicts with the observed increase in ROS 
59 
 
production due to BSO treatment.  Higher ROS production would be expected to lead to 
increased markers of lipid peroxidation including 4HNE.176 There is some evidence that the 
levels of 4HNE may intimately depend on cellular GSH concentration, whereby the 4HNE 
produced when cells are GSH-depleted may actually be more easily metabolized and broken 
down.177 Another perspective is the fact that a major route of 4HNE detoxification is through 
conjugation with GSH via the class of enzymes known as glutathione-S-transferases (GST).178 
Interestingly, it was found that 14 days of 30mM BSO treatment leads to paradoxically 
increased tissue GST activity.139 Therefore, it is possible an increased GST activity in BSO 
animals could lead to increased clearance of the 4HNE peroxidation product. This, in turn, 
could explain the decreased signal for 4HNE in our BSO-treated animals in the SOL. 
Quantification of GST protein and activity levels would be necessary to clarify this point; 
however, these analyses were not performed in the present work. There was no difference in 
CuZnSOD or MnSOD content as a result of age or BSO treatment. However, SOL catalase 
protein expression was substantially upregulated by 1.5-fold in older and 1.5-fold in BSO-
treated animals. This upregulated antioxidant defense is likely a compensatory effect that 
would serve to aid in muscle clearance of H2O2 in the absence of GSH as noted above. The 
reason for the differential response in ROS generation observed in SOL compared to WG 
following BSO treatment are unclear but may reflect a higher “oxidative environment” of the 
SOL,179, 180 which could have been augmented in a GSH-depleted state. For instance, 
malondialdehyde levels (MDA, a marker of lipid peroxidation) are higher in the SOL muscle 
compared to vastus lateralis in rats; additionally, enzyme activity for several antioxidants such 
as SOD, GPx and catalase are comparably elevated in the SOL.179 Other groups have shown 
similar results in terms of lipid peroxidation markers and antioxidant enzyme activity, and have 
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also demonstrated increased markers of mitochondrial density in SOL compared to less 
oxidative muscles such as red gastrocnemius or WG.180 
Effects of BSO treatment and age on apoptotic signaling in WG 
In the present investigation we found a 38% higher level of DNA fragmentation in WG of 
BSO-treated animals compared to untreated controls. In contrast, no differences in DNA 
fragmentation were observed in WG of older compared to younger animals. In addition, there 
were no significant differences in caspase-3, -8, or -9 activity between groups. The elevated 
DNA fragmentation in the absence of increased caspase activity in BSO-treated animals is 
surprising but could suggest that caspase-independent mechanisms are playing a role. For 
example, AIF and EndoG are two mitochondrial proteins that can lead to DNA fragmentation 
independent of caspase activation.32, 45 However, as discussed below, AIF-mediated signaling 
is likely not involved as we found decreased levels in cytosolic and nuclear fractions. It is 
possible that EndoG (or other factors) may have played a role in the observed effect; however, 
this remains to be determined. It is also possible that the increased rate of DNA fragmentation 
observed in BSO animals is attributable to other sources of nuclear material outside of 
myonuclei (ie. interstitial cells, macrophages).57, 181 Using TUNEL staining (a microscopic 
method which stains for fragmented DNA in muscle cross-sections) in a rabbit model of limb 
immobilization, Smith and colleagues reported that the majority of TUNEL-positive cells 
observed were outside of the outline of muscle fibers.181 A similar study using limb 
unweighting in rats showed that most TUNEL-stained nuclei were located in the interstitium or 
in connective tissue bands.57 In the present work, DNA fragmentation was only assessed using 
whole muscle homogenates, without the added compliment of TUNEL staining. Given that any 
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apoptotic interstitial or immune cells located in the muscle homogenate would be indiscernible 
from apoptotic myonuclei, the level of DNA fragmentation may have been overestimated. 
The lack of DNA fragmentation in WG of older animals is somewhat surprising; 
however, a closer examination of the literature may explain this finding. Previous work has 
shown an age-related increase in muscle apoptosis;64, 71, 73, 182 however, this is heavily 
dependent on the age of experimental animals. For example, Marzetti and colleagues have 
shown that DNA fragmentation in rat gastrocnemius muscle is not elevated in 18 month-old 
animals compared to adults (8 months), but is significantly increased at 29 months of age and 
older.183 This group also shows no change in several other apoptotic markers, such as Bax, 
active caspase-9, or mitochondrial Bid, between 8- and 18-month old animals.183 Similarly, the 
decrease in fiber CSA in the absence of increased DNA fragmentation in WG in older animals 
is also puzzling. However, recent advances in time-lapse microscopy have shown that CSA of 
fibers decreases in the absence of apoptotic nuclei during disuse atrophy.184 Atrophy and loss 
of muscle mass have been associated with the ATP-dependent ubiquitin-proteasome pathway 
of protein degradation, a process that may occur in the absence of classical markers of 
apoptosis (ie. DNA fragmentation).185 Tawa and colleagues have demonstrated attenuation of 
muscle wasting due to treatment with drugs that inhibit the proteasome, accompanied by 
decreased protein ubiquitination.186 In addition to the potential increased activity of this 
degradation pathway, aging muscle also displays decreased protein synthesis.187 Therefore, it is 
possible that a protein degradation pathway combined with decreased protein synthesis is 
involved in the atrophy observed in WG that is independent of apoptotic signaling. However, 
measures of proteasome activation, protein ubiquitination and protein synthesis were not 
performed in the present work. 
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Several anti-apoptotic proteins were also measured in WG muscle. Immunoblot 
analysis revealed no differences in both Hsp70 and Bcl-2 protein content across all groups. 
There was, however, a significant interaction in ARC protein with lower levels in the Young 
BSO compared to the Young CON. However, IHC analysis showed no significant differences 
in ARC protein between groups. This result is anomalous as there were no BSO-specific 
decreases in ARC observed in the Old groups. It is currently unclear what accounts for these 
differences.  
In general, we found very few changes in the level of several pro-apoptotic proteins in 
WG muscle between groups. For example, whole muscle Bax, Smac, AIF, and cytochrome c 
were all unchanged due to age or BSO treatment. Furthermore, there were no significant 
differences in the levels of cytosolic Smac or cytochrome c between all groups. In contrast, 
cytosolic and nuclear AIF were decreased in old animals, with no differences in response to 
BSO treatment. Siu and colleagues also found decreased nuclear AIF in aged mixed 
gastrocnemius muscle along with no change in cytosolic AIF levels and increased whole-tissue 
expression of this protein;188 however, the underlying reason for these findings was unclear. 
Collectively, the results of the current study suggest that the degree of aging in the animals 
used in this study was not sufficient to induce apoptosis but may be sufficient to induce a 
protein degradation pathway of muscle loss. 
Effects of age and BSO treatment on apoptotic signaling in SOL 
DNA fragmentation in SOL muscle was significantly elevated in BSO-treated animals 
compared to controls with no age-related changes noted in this measure. However, activity 
measures for three major caspases (caspase-3, -8, and -9) showed age-related differences, with 
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higher proteolytic activity found in older animals. The activity of these caspases was not 
different between groups in response to BSO treatment. This is somewhat puzzling given the 
role of caspases in apoptosis and DNA fragmentation. However, there is evidence that caspases 
do not exclusively function in apoptotic signaling (though that is their primary function). 
Recent work shows that caspase-3 and its downstream cleavage product caspase-activated 
DNase promote skeletal muscle cell differentiation by inducing essential DNA strand breaks in 
the terminal step of this process.189 Other groups have shown that myoblasts exposed to 
caspase-3 and caspase-8 inhibitors are unable to differentiate.190 This could be a reason for the 
increased caspase activation observed in aged SOL in the absence of DNA fragmentation. 
More specifically, given the higher muscle weights in old SOL, it is possible that activation of 
satellite cells (myoblasts) was increased. These myoblasts proliferate, differentiate and then 
incorporate into the muscle fiber to aid in muscle hypertrophy.191 Therefore, the increased 
caspase activity seen here may reflect a shift towards increased muscle regeneration in this 
tissue through induction of satellite cell differentiation and subsequent proliferation. However, 
this remains to be determined.  
The levels of several anti-apoptotic proteins (Hsp70, ARC, Bcl-2) were not affected by 
BSO treatment in SOL. Similarly, the levels of Bcl-2 protein were not affected by age. In 
contrast, Hsp70 protein content was significantly higher in old versus young animals. 
Interestingly, Hsp70 protein levels mirrored the increase in caspase activity in SOL, 
highlighting that advancing age may be inducing a state of cellular stress in this tissue.192 
Hsp70 expression has been shown to increase from middle-aged (16-month) to senescent (29-
month) rats, with a concomitant increase in cleaved caspase-9.193 Hsp70 has also been shown 
to interact with and antagonize Apaf-1, a necessary component of the caspase-9-activating 
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apoptosome.194 Some studies have shown that Hsp70 may exert its protective effects 
downstream of caspase-3 activation,195 thus allowing other cellular events of the caspase 
cascade to occur while inhibiting substrate cleavage and apoptotic death. Therefore, although 
caspase-3 and -9 activity was elevated, the increased Hsp70 content could have been sufficient 
to inhibit caspase-mediated DNA fragmentation and apoptotic events in older animals.  
 Several pro-apoptotic proteins were also measured in SOL. Whole muscle AIF and Bax 
content were not affected by age or BSO treatment. Similarly, whole-tissue Smac and 
cytochrome c levels were not affected by BSO treatment. In contrast, whole SOL Smac and 
cytochrome c were significantly decreased in older animals. Although at first glance it would 
seem that this may be indicative of less apoptosis in aged animals, it is important to note that 
these proteins are part of the mitochondria and generally have vital functions independent of 
their role in apoptosis.196 Release of these proteins from the mitochondrial intermembrane 
space into the cytosol is essential to their pro-apoptotic function.32, 33 Further, subcellular 
distribution studies performed here showed no effects similar to those observed in the whole 
tissue homogenate. In particular, age had no effect on cytosolic AIF, Smac or cytochrome c, 
nor on nuclear AIF. Decreased whole-tissue expression of mitochondrial apoptotic factors, in 
the absence of subcellular changes indicative of mitochondrial release of these apoptogenic 
proteins, may simply indicate decreased mitochondrial content. There is evidence to show a 
decrease in mitochondrial density in elderly humans compared to their adult counterparts.197 
Others have shown similar results, whereby mitochondrial content and other measures of 
mitochondrial density (mtDNA abundance and citrate synthase activity) are decreased in aged 
patients compared to younger counterparts.198 
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In contrast to the higher Hsp70 levels observed in older animals, anti-apoptotic ARC 
expression was decreased in SOL of older animals as assessed by both immunohistochemical 
analyses and immunoblot analysis. Similarly, Siu and Alway have demonstrated decreased 
expression of anti-apoptotic factors (ie. ARC, XIAP) and increased H2O2 levels in aged muscle 
after 7 days of loading compared to younger animals.199 Interestingly, ARC degradation has 
been shown to occur through the ubiquitin-proteasome in response to such cellular stress.6, 99 
Collectively, this ARC data along with the higher Hsp70 levels suggest that SOL muscle of 
older animals may have been under greater stress. However, this stress was not sufficient to 
increase DNA fragmentation (apoptosis) or muscle wasting.  
The data presented herein for WG and SOL suggest differential apoptotic effects due to 
BSO treatment and/or age. In WG, loss of muscle mass is apparent even in the absence of 
elevated apoptotic signaling while this trend does not hold in SOL. BSO-induced DNA 
fragmentation is observed in conjunction with oxidative modifications as assessed by GSH 
depletion and catalase upregulation in both tissues examined. 
Several tissue-specific changes were observed in this study 
There were several noteworthy differences observed between the two muscles tested in this 
study. As alluded to in the previous discussion, the higher mitochondrial volume of SOL 
compared to WG may result in increased ROS production. Although a direct analysis of 
mitochondrial volume or content was not performed between these two muscles, the 
differences are obvious when examining the absolute ROS production (Figure 7 in Results). 
Specifically, a substantially higher level of ROS production was observed in the slower, more 
oxidative SOL compared to the faster, more glycolytic WG. In support of this observation, 
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higher 4HNE immunofluorescent staining was seen in the more oxidative SOL muscle 
compared to the more glycolytic WG. This is consistent with reports indicating that 
malondialdehyde (MDA, a marker of lipid peroxidation) content was substantially increased in 
SOL muscle compared to WG.180 In addition, the 4HNE staining pattern observed between 
SOL and WG was very distinct: in WG more whole-fiber staining occurred, with smaller fibers 
more intensely stained than larger fibers. It is likely that these smaller fibers represent IIXB or 
IIX fibers, which are smaller than IIB200 (Bloemberg & Quadrilatero, 2010). Interestingly, IIX 
and IIXB fibers would tend to have a higher oxidative potential and therefore, mitochondrial 
content200 (Bloemberg & Quadrilatero, 2010). In the SOL, the cell membranes were more 
heavily stained compared to the inside of the fibers. The SOL staining pattern observed may be 
explained by the fact that 4HNE would be more likely to be found on or around the plasma 
membrane, due to the high concentration of polyunsaturated fatty acids which would be more 
susceptible to lipid peroxidation, ensuing radical chain reactions and formation of 4HNE 
adducts.176 In further support of the more oxidative environment of SOL muscle, both GSH 
and GSSG levels were found to be significantly higher in this muscle than WG. In fact, SOL 
GSH was higher than WG GSH across all groups including the BSO-treated groups. A similar 
trend persisted in terms of GSSG levels whereby SOL had consistently higher levels of GSSG 
across all groups compared to the same groups in WG. Similarly elevated basal GSH levels in 
oxidative muscles like SOL have been observed by others compared to more glycolytic 
muscles.179, 201  
DNA fragmentation levels were up to 12-fold higher in SOL compared to WG. 
Combined with the increased markers of oxidative stress in this muscle, this piece of data lends 
support to the link between oxidative stress and apoptotic signaling.75, 98 SOL also experiences 
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a 2-fold higher intensity of ARC staining compared to the more glycolytic WG that, when 
taken together with the increased DNA fragmentation rates observed, may be indicative of a 
protective mechanism developed by the muscle against endogenous damage. Our lab has 
observed similar increases in anti-apoptotic ARC protein expression in red gastrocnemius 
muscle compared to WG (McMillan & Quadrilatero, 2010). We have also shown elevated 
Hsp70 protein expression in slower muscle compared to fast, an observation consistent with 
the fiber-type specific expression of Hsp70.202 Slow muscles have higher protein levels of Bcl-
2 compared to their fast counterparts (McMillan & Quadrilatero, 2010). Lastly, slower muscles 
vary from their faster counterparts on other important markers of muscle health such as higher 
protein synthesis rates203 and increased satellite cell numbers associated with slow muscle 













The purpose of the present study was to explore the effects of glutathione depletion by BSO on 
apoptotic signaling in different types of young and old skeletal muscle. Apoptosis, as assessed 
by DNA fragmentation, was elevated in both the WG and SOL tissue due to BSO treatment. 
However, in WG this occurred in the absence of other pertinent markers of apoptotic signaling 
(ie. nuclear AIF translocation, increased caspase activity, mitochondrial release of 
Smac/cytochrome c, increased Bax, or decreased Bcl-2, ARC, Hsp70). No potent effects of 
aging were observed in the WG muscle other than loss of muscle mass as assessed by 
decreased muscle CSA. While the lack of DNA fragmentation and elevated apoptotic signaling 
in this tissue are contrary to the established literature, a possible explanation is offered by the 
fact that our old animals were not aged sufficiently to produce such effects. However, the age 
of the experimental animals offers an interesting perspective for examining the effects of in 
vivo antioxidant depletion. In other words, given the lack of change in basal GSH content in 
the Old CON animals compared to the Young CON, use of a chemical depletion model in 
addition to these age groups may show additive effects that could otherwise be lost in a model 
of advanced age. In particular, the elevated oxidative stress and apoptotic signaling typical of 
skeletal muscle from very old animals could confound any further effects of the BSO-induced 
GSH depletion in this tissue, making the age range of the animals used here useful for 
capturing any such synergistic effects. 
In the SOL muscle, while DNA fragmentation and ROS production increased in BSO-
treated animals, a slight decrease in 4HNE levels was observed. This is thought to result from 
elevated GST activity in these animals, though this point remains to be determined. A 
potentially elevated stress state may be occurring in aged SOL muscle, as evidenced by 
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elevated caspase activation and Hsp70 content as well as decreased levels of anti-apoptotic 
ARC. In addition, aged SOL muscle increased slightly in size in the present study, likely due to 
the increased body weight of older animals resulting in a greater load for this postural muscle 
to support as well as possible satellite cell activation. Furthermore, SOL muscle showed 
increased oxidative stress markers (ROS production and 4HNE levels), elevated DNA 
fragmentation and expression of ARC protein compared to WG, offering further evidence for 
the theory of elevated basal cellular stress occurring in more oxidative muscles compared to 
their more glycolytic counterparts (ie. SOL versus WG). Additionally, GSH and GSSG levels 
are elevated in SOL compared to WG which, taken together, indicate somewhat higher cellular 
stress accompanied by a greater antioxidant pool to handle that stress. 
Relating the experimental evidence back to the hypotheses postulated for this work, 
BSO treatment was effective in depleting muscle GSH. However, differential effects were 
observed in SOL and WG tissue in terms of the postulated increases in ROS production. Aging 
did not result in the anticipated increase in oxidative stress, nor did there appear to be any 
additive effect of BSO treatment and age on any measure other than catalase expression. GSH 
depletion was not sufficient to induce a classical apoptotic phenotype in either muscle type 
examined. Instead, in WG a process possibly related to a muscle degradation pathway emerged 
independent of apoptotic cell death with age, while BSO only resulted in disrupted thiol 
balance and upregulated catalase. In contrast, SOL muscle displayed an elevated state of 
cellular stress with age, experiencing disrupted thiol balance and only modest elevations in 
oxidative stress markers due to BSO treatment. Based on these data, BSO-induced GSH 
depletion does not seem to increase apoptotic signaling in either tissue examined, irrespective 
of age. The mid-range of the animals in this study helped to highlight the changes in apoptotic 
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There were several limitations to this study that are mostly methodological in nature. First, the 
muscles used were not weighed at the time of isolation, leaving the muscle cross-sectional area 
as the only estimate of muscle size. Having both CSA and muscle wet weight data could have 
strengthened the interpretations made herein concerning the observed changes in CSA of WG 
and SOL. Second, no measurements of GPx or GST activity were performed. These results 
could have helped clarify the extent to which the thiol system of the cell was impacted by the 
BSO-induced GSH depletion, or if there were any specific compensatory mechanisms at work 
as a result of the extreme GSH depletion observed.  
Focusing specifically on apoptotic signaling, with the exception of AIF protein levels 
and subcellular localization, no other measures of caspase-independent apoptosis were 
performed. In particular, no measure of protein levels or nuclear localization of Endonuclease 
G was performed. This protein is another important mitochondria-housed factor involved in 
caspase-independent cell death45. TUNEL staining could have helped clarify if the levels of 
DNA fragmentation observed were due to myonuclear loss or apoptotic processes in other cells 
present in whole skeletal muscle. Lastly, the idea of degradative mechanisms at work only in 
WG tissue would require quantification of proteasome activity, as well as measurement of 







As suggested throughout the discussion section of this thesis, there are several modifications 
that could have greatly improved the results obtained and that would be good starting points for 
future directions. Any further work in this area would benefit from examination of GST and 
GPx expression and enzyme activity quantification, as well as expression and subcellular 
localization of Endonuclease G. Additionally, while some studies have examined the 
potentially additive effects of stress (ie. exercise) on GSH-depleted animals82, 132, the focus on 
apoptotic effects of this elevated stress state has been absent. It would be interesting to 
consider young (4-8 months), middle-aged/adult (14-18 months) and old (24 months and 
above) GSH-depleted and control animals exposed to an eccentric exercise protocol such as 
treadmill running on a downward incline. In addition, consideration of acute and prolonged 
exposure to such exercise could clarify potentially protective effects, or demonstrate the 
additive negative effects of increased activity, lowered thiol content and changes in ROS 
production of this type of exercise. Since the muscle samples were taken after 10 days of 
treatment, it could be useful to isolate muscle tissue at different time points in the BSO 
treatment protocol. There is some evidence that BSO effectively depletes in vivo GSH levels as 
early as 24 hours after the first administration133.By examining different time points in a BSO 
drug treatment, it may be possible to more accurately pinpoint the occurrence of apoptotic 
signalling events in relation to the level of GSH depletion obtained by the administration of the 
drug. Furthermore, evaluation of the ubiquitin-proteasome system in the context of BSO-
induced GSH depletion in skeletal muscle could offer valuable insight into the potentially 
adverse whole-body effects of this drug. This would be important as BSO is currently under 
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